Protease inhibitor antipain reduces nuclear binding of estrogen-receptor complex in MCF-7 breast tumor cells

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Protease inhibitors are studied for their diverse cellular effects.
• Steroid hormone signaling pathways are crucial in cellular processes and disease.
• Understanding interactions between protease inhibitors and hormone signaling is important.

Purpose of the Study:

• To investigate the impact of protease inhibitors on steroid hormone-related cellular events.
• To identify specific hormone-related processes affected by protease inhibitors.
• To examine the effect of antipain on estradiol-receptor complex nuclear binding in breast cancer cells.

Main Methods:

• Cultured MCF-7 breast tumor cells were utilized.
• Cells were incubated in estradiol-containing medium.
• The effect of the protease inhibitor antipain on nuclear binding of the estradiol-receptor complex was measured.

Main Results:

• The presence of antipain during incubation with estradiol significantly reduced nuclear binding of the estradiol-receptor complex.
• This indicates a perturbation of estradiol hormone signaling by antipain.

Conclusions:

• Protease inhibitors, specifically antipain, can interfere with steroid hormone nuclear binding.
• Antipain's effect on estradiol-receptor complex binding suggests a potential role in modulating hormone-dependent processes in breast cancer cells.